Maxim upgraded Annovis Bio (ANVS) to Buy from Hold with a $25 price target Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>> See the top stocks recommended by analysts >> Read More on ANVS: Annovis Bio says FDA clears company to launch Phase 3 Alzheimer’s studies Annovis Bio Files Patents for Neurodegenerative Combination Therapies Annovis Bio files three new patents for combination therapies
